Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Genome evolution and early introductions of the SARS-CoV-2 Omicron Variant in Mexico

View ORCID ProfileHugo G. Castelán-Sánchez, View ORCID ProfileLeón P. Martínez-Castilla, View ORCID ProfileGustavo Sganzerla-Martínez, View ORCID ProfileJesús Torres-Flores, View ORCID ProfileGamaliel López-Leal
doi: https://doi.org/10.1101/2022.07.13.22277603
Hugo G. Castelán-Sánchez
1Programa de Investigadoras e Investigadores por México. Grupo de Genómica y Dinámica Evolutiva de Microorganismos Emergentes. Consejo Nacional de Ciencia y Tecnología. Av. Insurgentes Sur 1582, Crédito Constructor, Benito Juárez, CP 03940, Ciudad de México, México
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hugo G. Castelán-Sánchez
  • For correspondence: hugo.castelan{at}conacyt.mx
León P. Martínez-Castilla
1Programa de Investigadoras e Investigadores por México. Grupo de Genómica y Dinámica Evolutiva de Microorganismos Emergentes. Consejo Nacional de Ciencia y Tecnología. Av. Insurgentes Sur 1582, Crédito Constructor, Benito Juárez, CP 03940, Ciudad de México, México
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for León P. Martínez-Castilla
Gustavo Sganzerla-Martínez
2Laboratory of Immunity, Shantou University Medical College, Shantou, People’s Republic of China
3The Department of Microbiology and Immunology Dalhousie University, Halifax, NS, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gustavo Sganzerla-Martínez
Jesús Torres-Flores
1Programa de Investigadoras e Investigadores por México. Grupo de Genómica y Dinámica Evolutiva de Microorganismos Emergentes. Consejo Nacional de Ciencia y Tecnología. Av. Insurgentes Sur 1582, Crédito Constructor, Benito Juárez, CP 03940, Ciudad de México, México
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jesús Torres-Flores
Gamaliel López-Leal
1Programa de Investigadoras e Investigadores por México. Grupo de Genómica y Dinámica Evolutiva de Microorganismos Emergentes. Consejo Nacional de Ciencia y Tecnología. Av. Insurgentes Sur 1582, Crédito Constructor, Benito Juárez, CP 03940, Ciudad de México, México
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gamaliel López-Leal
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

A new variant of SARS-CoV-2 Omicron (Pango lineage designation B.1.1.529), was first reported to the World Health Organization (WHO) by South African health authorities on November 24, 2021. The Omicron variant possesses numerous mutations associated with increased transmissibility and immune escape properties. In November 2021, Mexican authorities reported Omicron’s presence in the country. In this study, we infer the first introductory events of Omicron and the impact that human mobility can have on the spread of the virus. We also evaluated the adaptive evolutionary processes in Mexican SARS-CoV-2 genomes during the first month of circulation of Omicron.

We infer 173 introduction events of Omicron in Mexico in the first two months of detection; subsequently, of the introductions, there was an increase in the prevalence for January.

This higher prevalence of the novel variant results in a peak of cases reported, on average, six weeks after a higher mobility trend was reported. The peak of cases reported is due to the BA.1.1 Omicron sub-lineage dominated, followed by BA.1 and BA.15 sub-lineages in the country from January to February 2022.

Additionally, we identified the presence of diversifying natural selection in the genomes of Omicron and found mainly five non-synonymous mutations in the RDB domain of the Spike protein, all of them related to evasion of the immune response. In contrast, the other proteins in the genome are highly conserved—however, there are homoplasies mutations in non-structural proteins, indicating a parallel evolution.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Hugo G Castelán-Sánchez hugo.castelan{at}conacyt.mx, León P. Martinez-Castilla leon.martinez{at}conacyt.mx, Gustavo Sganzerla Martínez gustavo.sganzerla{at}dal.ca, Jesús Torres-Flores jesus.torres{at}conacyt.mx, Gamaliel Lopez-Leal gamaliel.lopez{at}conacyt.mx

Data Availability

All data produced in the present work are contained in the manuscript

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted July 15, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Genome evolution and early introductions of the SARS-CoV-2 Omicron Variant in Mexico
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Genome evolution and early introductions of the SARS-CoV-2 Omicron Variant in Mexico
Hugo G. Castelán-Sánchez, León P. Martínez-Castilla, Gustavo Sganzerla-Martínez, Jesús Torres-Flores, Gamaliel López-Leal
medRxiv 2022.07.13.22277603; doi: https://doi.org/10.1101/2022.07.13.22277603
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Genome evolution and early introductions of the SARS-CoV-2 Omicron Variant in Mexico
Hugo G. Castelán-Sánchez, León P. Martínez-Castilla, Gustavo Sganzerla-Martínez, Jesús Torres-Flores, Gamaliel López-Leal
medRxiv 2022.07.13.22277603; doi: https://doi.org/10.1101/2022.07.13.22277603

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (427)
  • Allergy and Immunology (753)
  • Anesthesia (220)
  • Cardiovascular Medicine (3284)
  • Dentistry and Oral Medicine (362)
  • Dermatology (276)
  • Emergency Medicine (478)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1168)
  • Epidemiology (13346)
  • Forensic Medicine (19)
  • Gastroenterology (898)
  • Genetic and Genomic Medicine (5138)
  • Geriatric Medicine (480)
  • Health Economics (781)
  • Health Informatics (3260)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1189)
  • Hematology (428)
  • HIV/AIDS (1015)
  • Infectious Diseases (except HIV/AIDS) (14617)
  • Intensive Care and Critical Care Medicine (912)
  • Medical Education (476)
  • Medical Ethics (126)
  • Nephrology (522)
  • Neurology (4909)
  • Nursing (262)
  • Nutrition (725)
  • Obstetrics and Gynecology (880)
  • Occupational and Environmental Health (795)
  • Oncology (2517)
  • Ophthalmology (722)
  • Orthopedics (280)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (542)
  • Pediatrics (1299)
  • Pharmacology and Therapeutics (549)
  • Primary Care Research (555)
  • Psychiatry and Clinical Psychology (4198)
  • Public and Global Health (7489)
  • Radiology and Imaging (1703)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (979)
  • Rheumatology (479)
  • Sexual and Reproductive Health (496)
  • Sports Medicine (424)
  • Surgery (547)
  • Toxicology (72)
  • Transplantation (235)
  • Urology (203)